Department of Anaesthesiology and Critical Care Medicine, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Biostatistics Unit, DRCI, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Eur J Health Econ. 2024 Dec;25(9):1529-1537. doi: 10.1007/s10198-024-01686-y. Epub 2024 Mar 13.
Better cost-awareness is a prerogative in achieving the best benefit/risk/cost ratio in the care. We aimed to assess the cost-awareness of intensivists in their daily clinical practice and to identify factors associated with accurate estimate of cost (50-150% of the real cost).
We performed a prospective observational study in seven French ICUs. We compared the estimate of intensivists of the daily costs of caring with the real costs on a given day. The estimates covered five categories (drugs, laboratory tests, imaging modalities, medical devices, and waste) whose sum represented the overall cost.
Of the 234 estimates made by 65 intensivists, 70 (29.9%) were accurate. The median overall cost estimate (€330 [170; 620]) was significantly higher than the real cost (€178 [124; 239], p < 0.001). This overestimation was found in four categories, in particular for waste (€40 [15; 100] vs. €1.1 [0.6; 2.3], p < 0.001). Only the laboratory tests were underestimated (€65 [30; 120] vs. €106 [79; 138], p < 0.001). Being aware of the financial impact of prescriptions was factor associated with accurate estimate (OR: 5.05, 95%CI:1.47-17.4, p = 0.01). However, feeling able to accurately perform estimation was factor negatively associated with accurate estimate (OR: 0.11, 95%CI: 0.02-0.71, p = 0.02).
French intensivists have a poor awareness of costs in their daily clinical practice. Raising awareness of the financial impact of prescriptions, and of the cost of laboratory tests and waste are the main areas for improvement that could help achieve the objective of the best care at the best cost.
在医疗保健中,提高成本意识是实现最佳效益/风险/成本比的前提。我们旨在评估重症监护医生在日常临床实践中的成本意识,并确定与准确估计成本(实际成本的 50-150%)相关的因素。
我们在法国的 7 个 ICU 进行了一项前瞻性观察研究。我们比较了重症监护医生对特定日护理成本的估计与实际成本。估计涵盖了五个类别(药物、实验室检查、影像学检查、医疗器械和废物),这些类别的总和代表了总费用。
在 65 位重症监护医生做出的 234 项估计中,有 70 项(29.9%)是准确的。总体成本估计中位数(€330 [170;620])明显高于实际成本(€178 [124;239],p<0.001)。这种高估出现在四个类别中,特别是废物(€40 [15;100] vs. €1.1 [0.6;2.3],p<0.001)。只有实验室检查被低估(€65 [30;120] vs. €106 [79;138],p<0.001)。意识到处方的财务影响是与准确估计相关的因素(OR:5.05,95%CI:1.47-17.4,p=0.01)。然而,能够准确进行估计的感觉与准确估计呈负相关(OR:0.11,95%CI:0.02-0.71,p=0.02)。
法国重症监护医生在日常临床实践中对成本的认识较差。提高对处方的财务影响以及对实验室检查和废物成本的认识是提高成本意识的主要改进领域,这有助于实现以最佳成本提供最佳护理的目标。